MedPath
FDA Approval

Cortrosyn

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Henry Schein, Inc.
DUNS: 012430880
Effective Date
January 19, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tetracosactide(0.25 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cortrosyn

Product Details

NDC Product Code
0404-9839
Application Number
NDA016750
Marketing Category
NDA (C73594)
Route of Administration
PARENTERAL, INTRAVENOUS, INTRAMUSCULAR
Effective Date
January 9, 2022
Code: 72YY86EA29Class: ACTIBQuantity: 0.25 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath